By Michael Macagnone ( September 25, 2015, 12:47 PM EDT) -- The Internal Revenue Service wants a Tax Court judge to affirm its $100 million tax bill for Mylan Pharmaceutical Inc.'s 2008 $410 million drug development deal with Forest Laboratories, saying in a summary judgment filing last week the deal was clearly a license, not a sale....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.